Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FULC Fulcrum Therapeutics

交易中 12-19 12:43:25 EST

4.09

-0.14

-3.21%

最高4.34	最低4.09	成交量27.42万
今开4.30	昨收4.23	日振幅6.03%
总市值2.21亿	流通市值1.31亿	总股本5,394万
成交额113.83万	换手率0.86%	流通股本3,198万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FULC","market":"US","secType":"STK","nameCN":"Fulcrum Therapeutics","latestPrice":4.0942,"timestamp":1734630137284,"preClose":4.23,"halted":0,"volume":274203,"delay":0,"floatShares":31984600,"shares":53938661,"eps":-0.288364,"marketStatus":"交易中","marketStatusCode":2,"change":-0.1358,"latestTime":"12-19 12:43:25 EST","open":4.3,"high":4.34,"low":4.085,"amount":1138299.0235812,"amplitude":0.060284,"askPrice":4.1,"askSize":438,"bidPrice":4.09,"bidSize":369,"shortable":3,"etf":0,"ttmEps":-0.288364,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734642000000},"adr":0,"listingDate":1563422400000,"adjPreClose":4.23,"preHourTrading":{"tag":"盘前","latestPrice":4.33,"preClose":4.23,"latestTime":"09:25 EST","volume":303,"amount":1305.4799237999998,"timestamp":1734618313449},"postHourTrading":{"tag":"盘后","latestPrice":4.23,"preClose":4.23,"latestTime":"16:32 EST","volume":8211,"amount":34720.08,"timestamp":1734557543633},"volumeRatio":0.426459,"impliedVol":1.6308,"impliedVolPercentile":0.9643},"requestUrl":"/m/hq/s/FULC","defaultTab":"news","newsList":[{"id":"2491692770","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘大幅拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692770?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:48","pubTimestamp":1734360488,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时48分，Fulcrum Therapeutics, Inc.股票出现波动，股价大幅拉升5.30%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Viridian Therapeutics, Inc.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为42.27%、32.80%、30.78%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为38.10%、19.33%、19.23%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224808ab7c9ca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224808ab7c9ca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","FULC"],"gpt_icon":0},{"id":"2490872173","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490872173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490872173?lang=zh_cn&edition=full","pubTime":"2024-12-12 23:07","pubTimestamp":1734016055,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日23时07分，Fulcrum Therapeutics, Inc.股票出现波动，股价快速跳水5.00%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Palisade Bio, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Trevi Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3045.22%、756.04%、65.77%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Palisade Bio, Inc.，振幅分别为75.86%、71.35%、56.43%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212230735984b9845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212230735984b9845&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","FULC"],"gpt_icon":0},{"id":"2490773811","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.21%报4.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490773811","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490773811?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:33","pubTimestamp":1733754810,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时33分，Fulcrum Therapeutics, Inc.股票出现异动，股价大幅上涨5.21%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为2430.16%、23.78%、19.98%，振幅较大的相关个股有Rapport Therapeutics, Inc.、Passage Bio, Inc.、Nkgen Biotech, Inc.，振幅分别为106.84%、105.41%、104.58%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223330a1e0a935&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223330a1e0a935&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC","BK4139","BK4007"],"gpt_icon":0},{"id":"2489214963","title":"Fulcrum Therapeutics, Inc.盘中异动 下午盘急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489214963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489214963?lang=zh_cn&edition=full","pubTime":"2024-12-05 03:44","pubTimestamp":1733341440,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日03时44分，Fulcrum Therapeutics, Inc.股票出现异动，股价大幅跳水5.04%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Exicure, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为4639.59%、283.99%、144.55%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为548.98%、287.57%、64.57%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205034400a1d45213&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205034400a1d45213&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","FULC"],"gpt_icon":0},{"id":"2488468209","title":"Fulcrum Therapeutics, Inc.盘中异动 快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488468209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488468209?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:41","pubTimestamp":1733236899,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时41分，Fulcrum Therapeutics, Inc.股票出现波动，股价大幅跳水5.15%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Janux Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为132.67%、76.28%、60.87%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.、Senti Biosciences, Inc.，振幅分别为51.13%、24.09%、23.90%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224139abf2fe03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224139abf2fe03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","FULC"],"gpt_icon":0},{"id":"2486351868","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486351868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486351868?lang=zh_cn&edition=full","pubTime":"2024-11-27 03:45","pubTimestamp":1732650303,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日03时45分，Fulcrum Therapeutics, Inc.股票出现波动，股价快速拉升5.23%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Poseida Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，木薯科学、Elevai Labs, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为57.12%、52.10%、34.32%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Lakeshore Biopharma Co., Ltd，振幅分别为85.82%、57.50%、55.39%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127034504abe141e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127034504abe141e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","FULC"],"gpt_icon":0},{"id":"2485108298","title":"Fulcrum Therapeutics, Inc.2024财年第三财季实现净利润-21.70百万美元，同比增加9.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485108298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485108298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291206,"startTime":"0","endTime":"0","summary":"11月23日，Fulcrum Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-21.70百万美元，同比增加9.66%；其中营业收入为0.00美元，每股基本收益为-0.35美元。机构评级：截至2024年11月23日，当前有7家机构对Fulcrum Therapeutics, Inc.目标价做出预测，其中目标均价为5.29美元，其中最低目标价为2.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000015abd7b7bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000015abd7b7bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC"],"gpt_icon":0},{"id":"2485267314","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485267314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485267314?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:19","pubTimestamp":1732288764,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时19分，Fulcrum Therapeutics, Inc.股票出现异动，股价大幅拉升5.22%。截至发稿，该股报3.13美元/股，成交量17.8382万股，换手率0.33%，振幅6.06%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Replimune Group, Inc.、Virpax Pharmaceuticals, Inc.、奥麦罗制药涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1563.96%、110.36%、81.62%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为55.96%、45.86%、38.10%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122231924971a81f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122231924971a81f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","FULC"],"gpt_icon":0},{"id":"2483588053","title":"Fulcrum Therapeutics Inc 报告本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483588053","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483588053?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:26","pubTimestamp":1731511562,"startTime":"0","endTime":"0","summary":"Fulcrum Therapeutics Inc 报告本季度业绩 - 收益摘要Fulcrum Therapeutics Inc FULC.OQ报告本季度调整后每股亏损35美分，高于去年同期的每股-39美分。报告收入为零，分析师预期为零。Fulcrum Therapeutics Inc 报告的季度每股收益为亏损 35 美分。该公司当季亏损 2170 万美元。Fulcrum Therapeutics Inc 本季度股价上涨了 2.0%，今年迄今为止亏损了 46.1%。华尔街对 Fulcrum Therapeutics Inc 的 12 个月目标价中位数为 4.00 美元。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4S3MK1MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FULC","BK4007"],"gpt_icon":0},{"id":"2482739486","title":"Fulcrum Therapeutics Inc 预计每股亏损41美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482739486","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482739486?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:38","pubTimestamp":1731339518,"startTime":"0","endTime":"0","summary":"Fulcrum Therapeutics Inc 预计每股亏损41美分 - 财报前瞻Fulcrum Therapeutics Inc FULC.OQ FULC.O将于11月13日公布截至2024年9月30日的财报，预计该公司的季度收入将出现下降。LSEG分析师对Fulcrum Therapeutics Inc的平均预期是每股亏损41美分。华尔街对 Fulcrum Therapeutics Inc 的 12 个月目标价中位数为 4.00 美元，高于其上次收盘价 3.49 美元。11月11日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4S3MI15T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FULC"],"gpt_icon":0},{"id":"2481013184","title":"Fulcrum Therapeutics, Inc.盘中异动 大幅拉升5.54%报3.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481013184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481013184?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:46","pubTimestamp":1731001561,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日01时46分，Fulcrum Therapeutics, Inc.股票出现异动，股价急速拉升5.54%。截至发稿，该股报3.62美元/股，成交量44.8657万股，换手率0.72%，振幅5.98%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Celularity Inc.、Ensysce Biosciences, Inc.涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为904.92%、436.68%、115.97%，振幅较大的相关个股有Celularity Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为84.83%、72.18%、68.89%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110801460195bde879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110801460195bde879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC","BK4139","BK4007"],"gpt_icon":0},{"id":"2481532257","title":"Fulcrum Therapeutics, Inc.盘中异动 大幅上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481532257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481532257?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:50","pubTimestamp":1730742636,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时50分，Fulcrum Therapeutics, Inc.股票出现波动，股价快速上涨5.30%。截至发稿，该股报3.38美元/股，成交量51.8753万股，换手率0.83%，振幅7.17%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为384.94%、277.29%、79.95%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Neurogene Inc.，振幅分别为52.25%、45.39%、39.98%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105015036ab9f119a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105015036ab9f119a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","FULC","LENZ","BK4139"],"gpt_icon":0},{"id":"2477453418","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477453418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477453418?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:52","pubTimestamp":1729695120,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时52分，Fulcrum Therapeutics, Inc.股票出现异动，股价大幅下挫5.01%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1671.97%、1129.27%、367.19%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为71.86%、68.32%、64.81%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023225200a1e42bef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023225200a1e42bef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","FULC"],"gpt_icon":0},{"id":"2474237567","title":"Fulcrum Therapeutics, Inc.盘中异动 临近午盘大幅下跌5.28%报3.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474237567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474237567?lang=zh_cn&edition=full","pubTime":"2024-10-10 23:39","pubTimestamp":1728574771,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日23时39分，Fulcrum Therapeutics, Inc.股票出现异动，股价急速跳水5.28%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为298.73%、172.47%、109.40%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corp C/Wts 28/10/2027 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为106.67%、66.67%、49.35%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102339319719f8d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410102339319719f8d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","FULC"],"gpt_icon":0},{"id":"2472748330","title":"Fulcrum Therapeutics, Inc.盘中异动 股价大跌5.01%报3.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472748330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472748330?lang=zh_cn&edition=full","pubTime":"2024-10-01 02:23","pubTimestamp":1727720601,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日02时23分，Fulcrum Therapeutics, Inc.股票出现异动，股价急速跳水5.01%。截至发稿，该股报3.58美元/股，成交量44.1164万股，换手率0.71%，振幅6.37%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001022321ab67310c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001022321ab67310c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","FULC","BK4139","BK4007"],"gpt_icon":0},{"id":"2470086175","title":"Fulcrum Therapeutics, Inc.盘中异动 早盘急速上涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470086175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470086175?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:31","pubTimestamp":1727443874,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时31分，Fulcrum Therapeutics, Inc.股票出现异动，股价快速拉升5.70%。截至发稿，该股报4.23美元/股，成交量5.4262万股，换手率0.09%，振幅2.50%。Fulcrum Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Cardio Diagnostics Holdings Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为1852.79%、60.86%、44.67%，振幅较大的相关个股有Biomea Fusion, Inc.、Traws Pharma, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为8.98%、8.81%、8.64%。Fulcrum Therapeutics, Inc.公司简介：Fulcrum Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213114a1dd108c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213114a1dd108c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FULC","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2470517007","title":"BUZZ--美国股票走势-Crocs、First Solar、高通公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2470517007","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470517007?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:14","pubTimestamp":1727367247,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月26日 - 华尔街主要股指周四上涨，标普500指数创下历史新高，原因是美光公司的乐观预测重燃了人工智能热潮，而一份申请失业救济人数低于预期的报告舒缓了人们对劳动力市场的担忧。美东时间11:38，道琼斯工业平均指数  上涨0.5%，至42135.45点。标普500指数  上涨0.22%，报5,734.93 点；纳斯达克综合指数  上涨0.23%，报18,124.285点。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"19d76ac8a99e856ca115d767258d984a","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FANG","WVE","EOG","JEF","MRVL","CNX","LNG","CVX","UDOW",".SPX","3NVD.UK","COP","FULC",".DJI","L","UAA","HAL","TLN","DDM","WMB","QCOM","NQmain","AGIO","DOG","XOM","TQQQ","SHOT","RRC","SNX","2NVD.UK","CDE","KMX","SONO","DJX","CLNE","CROX",".IXIC"],"gpt_icon":1},{"id":"2470075677","title":"分析师称，辉瑞退出 Oxbryta 可能会加速竞争对手试验性镰状细胞药物的试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2470075677","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470075677?lang=zh_cn&edition=full","pubTime":"2024-09-26 23:36","pubTimestamp":1727364983,"startTime":"0","endTime":"0","summary":"Oxbryta是至少六种镰状细胞病治疗药物之一，主要用于轻度至中度症状的患者。至少有三家华尔街券商表示，撤销授权可能会导致立即加快对竞争对手的治疗遗传性疾病的药物进行试验，包括Agios Pharmaceuticals公司的   mitapivat和Fulcrum Therapeutics公司的   pociredir。Stifel 公司分析师 Dae Gon Ha 周四表示，Oxbryta 的停产可能会使绝大多数轻中度患者依赖化疗药物羟基脲。据辉瑞公司网站介绍，该公司还收购了另外两种试验性镰状细胞疗法，这两种疗法目前仍在临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"31475a2f05bb5a0cf2e7acfeae2c0e13","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","BK4533","LU0417517546.SGD","LU1057294990.SGD","LU0289739699.SGD","IE00B19Z3B42.SGD","LU0320765992.SGD","IE00BBT3K403.USD","LU1035775433.USD","SG9999001176.SGD","LU0256863811.USD","LU1894683348.USD","LU2236285917.USD","LU0234570918.USD","IE0002270589.USD","PIPR","LU0058720904.USD","VRTX","IE00BJT1NW94.SGD","BK4550","LU0061475181.USD","LU1023059063.AUD","BK4007","BK4567","IE000M9KFDE8.USD","IE00B19Z9Z06.USD","LU2237438978.USD","LU1066051498.USD","IE00BJJMRZ35.SGD","BK4532","LU0234572021.USD","LU0122379950.USD","LU2417539215.USD","LU1585245621.USD","LU0225771236.USD","SGXZ57979304.SGD","LU0868494617.USD","BK4534","IE00B19Z9P08.USD","LU0321505439.SGD","SG9999013999.USD","IE00B894F039.SGD","LU0321505868.SGD","LU2362540622.SGD","IE00BLSP4452.SGD","SG9999001176.USD","LU1093756168.USD","FULC","IE00BLSP4239.USD","BK4127"],"gpt_icon":1},{"id":"2470573006","title":"BUZZ-辉瑞撤出镰状细胞药物后，镰状细胞药物开发商数量增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2470573006","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470573006?lang=zh_cn&edition=full","pubTime":"2024-09-26 22:36","pubTimestamp":1727361370,"startTime":"0","endTime":"0","summary":"    9月26日 - ** Agios Pharmaceuticals   股价上涨~3%，报50.29美元；Fulcrum Therapeutics   上涨~20%，报4.15美元 ** 较大的竞争对手辉瑞  从所有获批市场撤出其镰状细胞病药物Oxbryta， ，理由是该药物有引发痛苦的并发症和死亡的风险。** 镰状细胞病是一种遗传性血液疾病，会影响红细胞中的血红蛋白** 分析师预计，该药的退出将有助于促进竞争对手镰状细胞病药物的试验注册。** Leerink Partners的分析师称，Oxbryta的退出可能会对FULC早期研究的入组产生积极影响，尤其是正在或曾经单独服用Oxbryta的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"31475a2f05bb5a0cf2e7acfeae2c0e13","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","LU0122379950.USD","LU0170899867.USD","LU0306807586.USD","LU0868494617.USD","BK4139","IE00BBT3K403.USD","SG9999011175.SGD","LU1894683264.USD","BK4581","LU0321505439.SGD","LU0234572021.USD","LU0306806265.USD","LU1066053197.SGD","IE0002270589.USD","LU0321505868.SGD","SG9999013999.USD","IE000M9KFDE8.USD","PFE","SG9999002224.SGD","BK4550","LU0456855351.SGD","IE00B19Z3B42.SGD","LU1066051498.USD","LU0985481810.HKD","LU1023059063.AUD","LU0289739699.SGD","SG9999002232.USD","BK4592","LU0225284248.USD","LU0225771236.USD","AGIO","LU1057294990.SGD","FULC","SG9999003800.SGD","BK4534","BK4588","IE00B19Z3581.USD","LU0058720904.USD","IE00BLSP4452.SGD","BK4007","LU1883839398.USD","SG9999001176.SGD","BK4568","BK4585","IE00BLSP4239.USD","LU1894683348.USD","SG9999001176.USD","BK4533"],"gpt_icon":1},{"id":"2467714846","title":"美国研究综述-星座能源公司、礼来公司、塔伦能源公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2467714846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467714846?lang=zh_cn&edition=full","pubTime":"2024-09-13 15:51","pubTimestamp":1726213914,"startTime":"0","endTime":"0","summary":"    路透9月13日 - 周五，华尔街证券分析师修改了对几家美国上市公司的评级和目标价，其中包括星座能源公司、礼来公司和泰伦能源公司。* Fulcrum Therapeutics Inc   ：加拿大皇家银行将目标价从15美元下调至4美元 * Fulcrum Therapeutics Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","KR","LU1267930813.SGD","LH","RH","MODV","VST","NRG","CPB","PLAY","LU0965509101.SGD","EW","ALK","CEG","GEV","IE00BMG7P587.USD","IBEX","VRDN","BK4105","KIDS","LLY","USB","JNJ","LU1165135440.EUR","FERG","TTD","AVTR","PEG","WDC","BK4216","TLN","FULC","HAL","BK4581","LU0234572021.USD","IE00BD4GTT62.SGD","LU1244550577.SGD","ORKA","ZBH","BK4592","BK4212","LU2298322129.HKD","LU0417517546.SGD","SHLS","IE00BLSP4239.USD","LU0130102774.USD","DOW"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.fulcrumtx.com","stockEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":0.396},{"period":"3month","weight":0.2261},{"period":"6month","weight":-0.3668},{"period":"1year","weight":-0.2855},{"period":"ytd","weight":-0.3733}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fulcrum Therapeutics, Inc.于2015年8月18日在特拉华州注册成立。他们是一家临床阶段的生物制药公司，致力于改善未满足医疗需求的遗传性疾病患者的生活，最初的重点是罕见疾病。他们开发了一种专有产品引擎，用于系统地识别和验证可能调节基因表达的细胞药物靶点，以治疗遗传定义疾病的已知根本原因。他们正在使用他们的产品引擎来识别可被小分子吸毒的目标，而不管基因错误表达的特定潜在机制。他们已经确定了治疗面肩肱型肌营养不良症（FSHD）和某些血红蛋白病（即镰状细胞病，SCD和b-地中海贫血）的根本原因的药物靶点。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.093943},{"month":2,"riseRate":0.6,"avgChangeRate":0.007062},{"month":3,"riseRate":0.2,"avgChangeRate":0.022339},{"month":4,"riseRate":0.2,"avgChangeRate":-0.189757},{"month":5,"riseRate":0.6,"avgChangeRate":0.060108},{"month":6,"riseRate":0.4,"avgChangeRate":-0.04331},{"month":7,"riseRate":0.6,"avgChangeRate":0.083911},{"month":8,"riseRate":0.5,"avgChangeRate":0.487567},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.171434},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.105879},{"month":11,"riseRate":0.833333,"avgChangeRate":0.258816},{"month":12,"riseRate":1,"avgChangeRate":0.193265}],"exchange":"NASDAQ","name":"Fulcrum Therapeutics","nameEN":"Fulcrum Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fulcrum Therapeutics(FULC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fulcrum Therapeutics,FULC,Fulcrum Therapeutics股票,Fulcrum Therapeutics股票老虎,Fulcrum Therapeutics股票老虎国际,Fulcrum Therapeutics行情,Fulcrum Therapeutics股票行情,Fulcrum Therapeutics股价,Fulcrum Therapeutics股市,Fulcrum Therapeutics股票价格,Fulcrum Therapeutics股票交易,Fulcrum Therapeutics股票购买,Fulcrum Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fulcrum Therapeutics(FULC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fulcrum Therapeutics(FULC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况